An investigation of pharmaceutical drug misuse and harms among drug treatment clients in Victoria, Tasmania, West Australia and Queensland

  • Research program: Prevention and early intervention
  • Project status: Completed
  • Start date: March 2008
  • Expected end date: August 2008
  • Completion date: November 2010
  • Funded by: Ministerial Council on Drugs
  • Lead organisation:

This project is a multisite study involving Western Australia, Tasmania, Victoria and Queensland. The study is being co-ordinated by Turning Point Alcohol and Drug Centre in Melbourne. The project involves qualitative and quantitative interviews with 100 drug treatment clients (in each state) who acknowledge use of pharmaceutical drugs (benzodiazepines and opioids) in the past six month and interviews with key informants experienced in illicit drug treatment. A random selection of client case notes will be accessed and interpreted by an addiction expert from Turning Point for problems associated with drug treatment and the concomitant use of illicitly obtained pharmaceutical drugs.

Name & Contact Details Role Research Program Location
  • Principal Investigator: Mark Stoove, Burnet Institute
  • Co-investigator: Susan Carruthers, Curtin University

This project aligns with the following Sustainable Development Goals and Targets:

Nielsen, S., Bruno, R., Degenhardt, L., Stoove, M., A., Fischer, J., Carruthers, S. and Lintzeris, N. (2013). The sources of pharmaceuticals for problematic users of benzodiazepines and prescription opioids. Medical Journal of Australia, 199, (10), pp. 696-699. doi:10.5694/mja13.11331 [RJ892] View web page